Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Reactogenicity and Immunogenicity of Vaginal CNgp140 (SG06RS02)

This study has been terminated.
(IMP expired prior to completion of recruitment)
Sponsor:
Collaborators:
Bill and Melinda Gates Foundation
York Hospitals
Information provided by:
St George's, University of London
ClinicalTrials.gov Identifier:
NCT00637962
First received: March 11, 2008
Last updated: February 10, 2011
Last verified: February 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2009
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):